Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 3
1982 1
1983 1
1985 2
1986 2
1988 2
1989 2
1990 1
1991 2
1992 3
1993 3
1994 4
1995 2
1996 1
1998 4
1999 2
2000 1
2001 3
2002 5
2003 1
2004 4
2006 6
2007 3
2008 17
2009 14
2010 14
2011 14
2012 16
2013 13
2014 19
2015 18
2016 10
2017 8
2018 16
2019 6
2020 2
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d'Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study. Tusch E, et al. Clin Infect Dis. 2024 Apr 26:ciae228. doi: 10.1093/cid/ciae228. Online ahead of print. Clin Infect Dis. 2024. PMID: 38663013
Evolving epidemiology of HIV/AIDS in Campania region, 2011-2018: Is HIV/AIDS population in Campania different?
Fusco FM, Sangiovanni N, Mascolo S, Carleo MA, Sardo M, Viglietti R, Parrella G, Tambaro O, Iodice V, Di Flumeri G, Menna A, Galano A, Laudiero A, Mariniello A, De Cenzo M, Manzillo E, Esposito V, Chirianni A, Sangiovanni V. Fusco FM, et al. Among authors: chirianni a. SAGE Open Med. 2022 Jul 27;10:20503121221113938. doi: 10.1177/20503121221113938. eCollection 2022. SAGE Open Med. 2022. PMID: 35924140 Free PMC article.
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT).
Mussini C, Falcone M, Nozza S, Sagnelli C, Parrella R, Meschiari M, Petrosillo N, Mastroianni C, Cascio A, Iaria C, Galli M, Chirianni A, Sagnelli E, Iacobello C, Di Perri G, Mazzotta F, Carosi G, Tinelli M, Grossi P, Armignacco O, Portelli V, Andreoni M, Tavio M; Italian Society of Infectious and Tropical Diseases. Mussini C, et al. Among authors: chirianni a. Clin Microbiol Infect. 2021 Mar;27(3):389-395. doi: 10.1016/j.cmi.2020.12.011. Epub 2021 Jan 18. Clin Microbiol Infect. 2021. PMID: 33359375 Free PMC article.
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?
Shanyinde M, Girardi E, Puoti M, De Luca A, Sighinolfi L, Caterina UF, Caramello P, Lampe FC, D'Arminio Monforte A, Cozzi-Lepri A; ICONA Foundation Study Group. Shanyinde M, et al. BMC Public Health. 2019 Oct 15;19(1):1291. doi: 10.1186/s12889-019-7608-1. BMC Public Health. 2019. PMID: 31615542 Free PMC article.
Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials.
Lathouwers E, Wong EY, Brown K, Baugh B, Ghys A, Jezorwski J, Mohsine EG, Van Landuyt E, Opsomer M, De Meyer S; AMBER and EMERALD Study Groups. Lathouwers E, et al. AIDS Res Hum Retroviruses. 2020 Jan;36(1):48-57. doi: 10.1089/AID.2019.0111. Epub 2019 Oct 21. AIDS Res Hum Retroviruses. 2020. PMID: 31516033 Free PMC article. Clinical Trial.
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.
Gianotti N, Lorenzini P, Cozzi-Lepri A, De Luca A, Madeddu G, Sighinolfi L, Pinnetti C, Santoro C, Meraviglia P, Mussini C, Antinori A, d'Arminio Monforte A; ICONA Foundation Study Group. Gianotti N, et al. J Antimicrob Chemother. 2019 Sep 1;74(9):2732-2741. doi: 10.1093/jac/dkz237. J Antimicrob Chemother. 2019. PMID: 31173639
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons.
Guaraldi G, Marcotullio S, Maserati R, Gargiulo M, Milic J, Franconi I, Chirianni A, Andreoni M, Galli M, Lazzarin A, D'Arminio Monforte A, Di Perri G, Perno CF, Puoti M, Vella S, Di Biagio A, Maia L, Mussi C, Cesari M, Antinori A. Guaraldi G, et al. Among authors: chirianni a. J Frailty Aging. 2019;8(1):10-16. doi: 10.14283/jfa.2018.42. J Frailty Aging. 2019. PMID: 30734825
Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons.
Antinori A, Di Biagio A, Marcotullio S, Sarmati L, Andreoni M, Angarano G, Chirianni A, d'Arminio Monforte A, Di Perri G, Galli M, Gianotti N, Girardi E, Gori A, Mussini C, Perno CF, Lazzarin A. Antinori A, et al. Among authors: chirianni a. New Microbiol. 2018 Oct;41(4):247-255. New Microbiol. 2018. PMID: 30604833 Free article. Review.
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014.
d'Arminio Monforte A, Diaz-Cuervo H, De Luca A, Maggiolo F, Cingolani A, Bonora S, Castagna A, Girardi E, Antinori A, Lo Caputo S, Guaraldi G, Cozzi-Lepri A; ICONA Foundation Study Group. d'Arminio Monforte A, et al. HIV Med. 2019 Feb;20(2):99-109. doi: 10.1111/hiv.12683. Epub 2018 Nov 21. HIV Med. 2019. PMID: 30461158 Free article.
210 results